OVARIAN CARCINOSARCOMA
Clinical trials for OVARIAN CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for OVARIAN CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for Hard-to-Treat ovarian cancer
Disease control OngoingThis study tests whether adding the experimental drug AZD1775 to standard chemotherapy (gemcitabine) helps women with ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum-based treatments. About 124 participants will receive either the combination…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Your own tumor cells could fight your cancer: new trial tests personalized T-Cell therapy
Disease control OngoingThis phase 2 trial tests a personalized cell therapy called LN-145 for people with certain advanced cancers (like ovarian, breast, thyroid, or bone cancers) that have not responded to treatment or have returned. The therapy uses a patient's own immune cells, taken from their tumo…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC